{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:37:34Z","timestamp":1770557854065,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.clinthera.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T14:16:51Z","timestamp":1343830611000},"page":"1999-2010","source":"Crossref","is-referenced-by-count":13,"title":["Bioavailability and Tolerability of Combination Treatment With Revaprazan 200 mg + Itopride 150 mg: A Randomized Crossover Study in Healthy Male Korean Volunteers"],"prefix":"10.1016","volume":"34","author":[{"given":"Hee Youn","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yook-Hwan","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Joon","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeryoung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Bok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyun-Seop","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Seok","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.07.004_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cgh.2010.03.003","article-title":"Functional dyspepsia impacts absenteeism and direct and indirect costs","volume":"8","author":"Brook","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2012.07.004_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0016-5085(86)90451-8","article-title":"Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia","volume":"91","author":"Talley","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2012.07.004_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","article-title":"Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up","volume":"318","author":"Talley","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2012.07.004_bib5","first-page":"2323","article-title":"Functional (non-ulcer) dyspepsia and Helicobacter pylori infection","volume":"45","author":"Hammett","year":"1999","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clinthera.2012.07.004_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5056\/jnm.2011.17.3.235","article-title":"Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction","volume":"17","author":"Ghoshal","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.clinthera.2012.07.004_bib7","first-page":"511","article-title":"Appendix B: Rome III diagnostic criteria for functional gastrointestinal disorders [in Spanish]","volume":"75","author":"Drossman","year":"2010","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.clinthera.2012.07.004_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2982.2005.00675.x","article-title":"Basic and clinical pharmacology of new motility promoting agents","volume":"17","author":"Galligan","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.clinthera.2012.07.004_bib9","first-page":"9","article-title":"Functional dyspepsia: a pragmatic approach","volume":"48","author":"Giurcan","year":"2010","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2012.07.004_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.amjmed.2004.01.008","article-title":"Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials","volume":"116","author":"Peura","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF02850295","article-title":"Latin American open-label study with rabeprazole in patients with functional dyspepsia","volume":"17","author":"Mundo-Gallardo","year":"2000","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib14","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1046\/j.1365-2036.2001.01123.x","article-title":"Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia","volume":"15","author":"Schwartz","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib15","doi-asserted-by":"crossref","first-page":"G278","DOI":"10.1152\/ajpgi.00086.2003","article-title":"Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans","volume":"286","author":"Lee","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3904\/kjim.1997.12.2.188","article-title":"Hypersensitivity to acid in ulcer-like functional dyspepsia","volume":"12","author":"Son","year":"1997","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2036.2003.01651.x","article-title":"Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?","volume":"18","author":"Bolling-Sternevald","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2036.2011.04918.x","article-title":"Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects","volume":"35","author":"Oshima","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2005.085365","article-title":"Impaired gastric accommodation and its role in dyspepsia","volume":"55","author":"Kindt","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2012.07.004_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/gut.44.1.55","article-title":"Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function","volume":"44","author":"Thumshirn","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2012.07.004_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","article-title":"Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia","volume":"98","author":"Sarnelli","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.coph.2008.09.009","article-title":"Prokinetics and fundic relaxants in upper functional GI disorders","volume":"8","author":"Tack","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1746.2006.04493.x","article-title":"Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia","volume":"22","author":"Hiyama","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2982.2009.01261.x","article-title":"A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia","volume":"21","author":"Tack","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.clinthera.2012.07.004_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4166\/kjg.2011.57.2.67","article-title":"Guidelines for the treatment of functional dyspepsia","volume":"57","author":"Jee","year":"2011","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00535-009-0173-0","article-title":"The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying","volume":"45","author":"Futagami","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11938-005-0010-3","article-title":"Idiopathic dyspepsia","volume":"8","author":"Stanghellini","year":"2005","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib28","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1440-1746.2010.06408.x","article-title":"Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects","volume":"25","author":"Kim","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0091270003261321","article-title":"Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers","volume":"44","author":"Yu","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib30","first-page":"17","article-title":"Revaprazan (Revanex), a novel acid pump antagonist, for duodenal ulcer: results of a double-blind, randomized, parallel, multi-center phase III clinical trial [in Korean]","volume":"31","author":"Chung","year":"2005","journal-title":"Korean J. Gastrointest Endosc"},{"key":"10.1016\/j.clinthera.2012.07.004_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gut.2007.132449","article-title":"Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials","volume":"57","author":"Talley","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2012.07.004_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/BF03256924","article-title":"Itopride in the treatment of functional dyspepsia in chinese patients: a prospective, multicentre, post-marketing observational study","volume":"31","author":"Sun","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2012.07.004_bib33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","article-title":"A placebo-controlled trial of itopride in functional dyspepsia","volume":"354","author":"Holtmann","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib34","first-page":"547","article-title":"Update on the evaluation and management of functional dyspepsia","volume":"83","author":"Loyd","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2012.07.004_bib35","first-page":"45","article-title":"ICH harmonized tripartite guideline: Guideline for Good Clinical Practice","volume":"47","year":"2001","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib36","first-page":"41","article-title":"[The Helsinki Declaration]","volume":"29","year":"2010","journal-title":"Assist Inferm Ric"},{"key":"10.1016\/j.clinthera.2012.07.004_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.aca.2006.09.061","article-title":"Determination of itopride in human plasma by liquid chromatography coupled to tandem mass spectrometric detection: application to a bioequivalence study","volume":"583","author":"Lee","year":"2007","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.clinthera.2012.07.004_bib39","series-title":"Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications","author":"Rowland","year":"2011"},{"key":"10.1016\/j.clinthera.2012.07.004_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.clpt.6100054","article-title":"Drug interaction studies: study design, data analysis, and implications for dosing and labeling","volume":"81","author":"Huang","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/MOG.0b013e328313b983","article-title":"Dyspepsia","volume":"24","author":"Quigley","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/003655299750025237","article-title":"Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic\/International Gastroenterology Surveillance Study (DIGEST)","volume":"231","author":"Stanghellini","year":"1999","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.clinthera.2012.07.004_bib43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00003495-200363090-00003","article-title":"New developments in the treatment of functional dyspepsia","volume":"63","author":"Stanghellini","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2012.07.004_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MOG.0b013e32833ea9d9","article-title":"Adverse effects of proton pump inhibitor drugs: clues and conclusions","volume":"26","author":"McCarthy","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajcp\/110.5.615","article-title":"Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics","volume":"110","author":"Choudhry","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clinthera.2012.07.004_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2036.2000.00768.x","article-title":"Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors","volume":"14","author":"Laine","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.07.004_bib47","first-page":"1451","article-title":"[Risk of long-term treatment with proton pump inhibitors]","volume":"58","author":"Mathieu","year":"2008","journal-title":"Rev Prat"},{"key":"10.1016\/j.clinthera.2012.07.004_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5009\/gnl.2010.4.1.25","article-title":"A matched case-control study of a novel Acid-pump antagonist and proton-pump inhibitor for the treatment of iatrogenic ulcers caused by endoscopic submucosal dissection","volume":"4","author":"Kim","year":"2010","journal-title":"Gut Liver"},{"key":"10.1016\/j.clinthera.2012.07.004_bib49","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0026-895X(24)12055-X","article-title":"The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate","volume":"28","author":"Mushiroda","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2012.07.004_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1620\/tjem.224.293","article-title":"The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarin","volume":"224","author":"Jung","year":"2011","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1592\/phco.26.3.341","article-title":"Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers","volume":"26","author":"Tomilo","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2012.07.004_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/0003-4819-115-7-540","article-title":"Influence of gastric acidity on the bioavailability of digoxin","volume":"115","author":"Cohen","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2012.07.004_bib53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.19094","article-title":"Potential interaction between methotrexate and omeprazole","volume":"34","author":"Beorlegui","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2012.07.004_bib54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10620-009-0851-z","article-title":"Omeprazole induces gastric permeability to digoxin","volume":"55","author":"Gabello","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2012.07.004_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.phrs.2008.11.007","article-title":"Determination of itopride hydrochloride in human plasma by RP-HPLC with fluorescence detection and its use in bioequivalence study","volume":"59","author":"Ma","year":"2009","journal-title":"Pharmacol Res"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812004316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812004316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:45:45Z","timestamp":1743939945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812004316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0149291812004316"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.07.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}